Wednesday, November 5, 2014
Imagine earning 93% annual returns… In ten years, that would turn $10,000 into more than $7 million… Sound impossible? Today, we’ll introduce you to an investor in the private market who’s done it.
Thursday, October 30, 2014
2012 was an historic year. Not only was the JOBS Act passed, setting the stage for all citizens to invest in private equity...
Wednesday, October 29, 2014
Editor’s Note: Wayne and Matt are presenting at a big investing conference this week in Southern California: While they’re busy spreading the equity crowdfunding gospel, our Publisher has offered to step in and share the below opportunity with you.…
Thursday, October 9, 2014
We often write about exciting technologies... About companies that can change the world: Robotic exoskeletons, 4D Printing, drones – ideas that get the heart pumping.
Wednesday, October 8, 2014
Were you a victim of last week’s terrifying cyber-attack? If not, consider yourself lucky… 76 million households and 7 million small businesses were hacked.
Wednesday, October 1, 2014
Wayne recently shared a great real-world story… It was about private investors trouncing public investors on the same investment: Investors who bought shares of ReWalk Robotics (NASDAQ: RWLK) at the IPO made 116%. But investors who got in before the IPO made 381%.
Friday, September 19, 2014
You rely on Crowdability to bring you the best deals. Now, rely on us to share the most up-to-date news, trends and opinion.
Wednesday, September 17, 2014
Investment opportunities in crowdfunding are rapidly evolving: Initially, we showed you how to invest in start-ups for capital appreciation . Then we showed you how to invest in Real Estate and “Peer-to-Peer” loans to earn yield .
Wednesday, September 10, 2014
It was the media event of the year... Apple (AAPL) executives took to the stage yesterday to make two major announcements: The first was the launch of the new iPhone: the iPhone 6.
Thursday, August 21, 2014
"If we find cancer early, 90 percent survive. If we find cancer late, 10 percent survive." The above quote, from Wired Magazine, helps explain why certain bio-tech start-ups are shifting their focus: They’re shifting from cancer treatment to cancer detection.